WHITEHAWK THERAPEUTICS, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of -$77.30 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-12
- WHITEHAWK THERAPEUTICS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was -$77.30M, a 255.22% decline from fiscal 2024.
- WHITEHAWK THERAPEUTICS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $49.80M, a 156.70% increase from fiscal 2023.
- WHITEHAWK THERAPEUTICS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $19.40M, a 34.72% increase from fiscal 2022.
- WHITEHAWK THERAPEUTICS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $14.40M, a 48.94% decline from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$77.30M 10-K · filed 2026-03-12 | |
| 2024-12-31 | $49.80M 10-K · filed 2026-03-12 | |
| 2023-12-31 | $19.40M 10-K · filed 2025-03-28 | |
| 2022-12-31 | $14.40M 10-K · filed 2024-03-13 | |
| 2021-12-31 | $28.20M 10-K · filed 2023-03-29 | |
| 2020-12-31 | $1.60M 10-K · filed 2022-03-17 | $1.30M 10-K · filed 2021-03-11 |
| 2019-12-31 | $5.74M 10-K · filed 2021-03-11 | |
| 2018-12-31 | $2.83M 10-K · filed 2020-03-16 | $2.83M 10-K · filed 2019-03-07 |
| 2017-12-31 | -$3.77M 10-K · filed 2019-03-07 | |
| 2016-12-31 | $6.33M 10-K · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |